N. Bertrand
Molecular Biology · Advanced Drug Delivery Reviews · 2012–2017
A researcher in the Science corpus: 5 papers; trusts 19 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 133 citations into it; #16,781 of 17,773 by trust here, #7,747 by citations
- Biomaterials — 107 citations into it; #1,960 of 2,152 by trust here, #934 by citations
- Biomedical Engineering — 75 citations into it
- Electronic, Optical and Magnetic Materials — 26 citations into it
- Immunology — 23 citations into it
- Cancer Research — 21 citations into it
- Pharmaceutical Science — 15 citations into it
- Physiology — 11 citations into it
Whom N. Bertrand trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- O. Farokhzad
- Rakesh K. Jain
- Mark E. Davis
- R. Duncan
- Vladimir Torchilin
- J. Champion
- Robert Langer
- H. Maeda
- M. Swartz
- Kathryn A. Whitehead
Who trusts N. Bertrand overall
Papers from N. Bertrand's perspective
Ordered by how strongly the researchers N. Bertrand trusts endorse each paper. Same corpus, a different order for every researcher.
- Nanoparticle therapeutics: an emerging treatment modality for cancer (Nature reviews. Drug discovery)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
- Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
- The effect of particle design on cellular internalization pathways (Proceedings of the National Academy of Sciences of the United States of America)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
Their papers
- Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012) — 406 citations
- The journey of a drug-carrier in the body: an anatomo-physiological perspective. (2012) — 647 citations
- Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014) — 2,587 citations
- Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics (2017) — 600 citations
- Cancer Nanomedicine: From Targeted Delivery to Combination Therapy (2015) — 644 citations